-
BioFlorida:
WHAT: BioFlorida's annual event that celebrates and promotes the ongoing achievements of Florida's Northeast bioscience community. This ...
-
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c92257) has announced the addition of "The Future of White Biotechn...
-
The American Institute of Chemical Engineers (AlChE; New York) has agreed to acquire the American Chemical Society's (ACS; Washington, D.C.) 50 per ce...
-
The pool of donors for cornea transplants has been expanded by up to 30 percent, thanks to a federally funded study showing corneas from older donors can be used successfully. It was assumed previously - without any clinical proof - that younger donor tissue always was best.
The cornea, the protective transparent outer layer of the eye, is one of the most sensitive tissues in the body. If the tissue - which normally acts as a focusing instrument - is severely injured or diseased, the result can be blurred vision or even blindness. More than 10 million people around the world are blind because of diseased corneas, according to a June report in the journal Biotechnology Progress.
-
The American patent system stems from Article I, Section 8, of the US Constitution, which authorizes Congress to promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries. The fundamental idea driving the patent system was that Congress wanted to reward inventors with the right to exclude others from making, using, selling, or offering to sell their invention in exchange for the inventors' voluntary disclosure of the detailed workings of their discovery to the public. To enforce these exclusive rights, Congress empowered patent holders to bring an infringement suit against persons using, practicing, selling, or offering to sell the invention without obtaining permission from th...
... care provider use of patented biotechnology in subsequent legislation. Part II examines the le...
-
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c37685) has announced the addition of Espicom Business Intelligence...
-
To: NATIONAL EDITORS
WASHINGTON, Jan. 29 /PRNewswire-USNewswire/ -- The Bienville Democratin Arcadia, LA recently reported that America's pharmaceutical research and biotechnology companieshave made great progress in treating cancers, introducing many new, breakthrough medicines.
-
Panel discussion with Georgetown experts to address biotechnology, science, policy and ethical issues
WASHINGTON, June 22 /PRNewswire-USNewswire/ -- Earlier this week, the National Institutes of Health and the Food and Drug Administration outlined a "path" to accelerate and help ensure the safety of personalized medicine -- treatments tailored to match a person's genetic make-up. Significant progress in this rapidly developing field will hinge on biotechnology and will be impacted by the law, healthcare policy and ethical issues.
-
... of citation from journals likes Biotechnology Progress (02), Chemical Research in Toxicology (03...
-
... concerns without completely stifling the progress of biotechnology, international states ratified th...